Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease

被引:12
|
作者
Giladi, Nir [3 ]
Mirelman, Anat [1 ,4 ]
Thaler, Avner
Bar-Shira, Anat [2 ]
Gurevich, Tanya [3 ]
Orr-Urtreger, Avi [2 ,3 ]
机构
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Movement Disorders Unit, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Univ, Tel Aviv Med Ctr, Genet Inst, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-64239 Tel Aviv, Israel
[4] Ben Gurion Univ Negev, Beer Sheva, Israel
关键词
Parkinson's disease; LRRK2; gene; Clinical counseling; SMELL IDENTIFICATION TEST; OLFACTORY FUNCTION; ASHKENAZI JEWS; LRRK2; G2019S; EARLY-ONSET; MUTATIONS; NEUROPROTECTION; UNIVERSITY; MECHANISM; EXPOSURE;
D O I
10.1016/j.jns.2011.06.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Parkinson's disease (PD) has a long pre-diagnosis phase that may span as long as 10-20 years. The ability to identify at risk populations raises the possibility of early intervention to delay or prevent the onset of motor symptoms. In Israel, there is a large group of Ashkenazi Jews at risk of developing PD due to high frequency of PD associated mutations in 2 genes (GBA and LRRK2). Objective: To describe our unique experience with a clinical counseling service for 1st degree relatives of PD patients from the Ashkenazi origin who carry the G2019S mutation in the LRRK2 gene. Method: One hundred, self declared, healthy, first degree relatives of PD patients who carry the G2019S mutation in the LRRK2 gene were tested clinically and genetically in a cross sectional study. Those who have requested information on their risk to develop PD were invited to a free of charge, clinical counseling session to provide information on their risk of developing PD and potential risk modifiers that can be applied. Genetic status was not disclosed and the counselor was unaware of the subjects' G2019S mutation status. Results: 46 subjects (mean age 48.2 +/- 10.7; 46% males) came for clinical counseling provided by a Movement Disorders specialist Siblings and off-springs of the same proband were seen together. Counseling provided general information about the pre-diagnosis phase of PD, the concept of population at risk and habitual and behavioral recommendations that may delay PD motor symptoms onset. Conclusion: A high percentage of individuals at risk for developing PD requested clinical counseling on modifiers of the risk to develop PD. Counseling provided information as well as recommendations for behavioral modifications and drug treatment. Screening population at risk increases the awareness as well as early diagnosis of PD. Prospective information is needed in order to improve our knowledge base and assess the long term impact of such a counseling service. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [21] The role of telephone counseling in patients with Parkinson's disease
    Kim, M. S.
    Chung, S. J.
    Kim, S. R.
    Lee, T. Y.
    Lee, C. S.
    Lee, M. C.
    MOVEMENT DISORDERS, 2007, 22 : S75 - S75
  • [22] Genetic counseling in Parkinson's disease
    Foroud, T
    MOVEMENT DISORDERS, 2006, 21 : S11 - S11
  • [23] Counseling Persons with Parkinson's Disease
    Choi, Namkee G.
    JOURNAL OF GERONTOLOGICAL SOCIAL WORK, 2022, 65 (01): : 112 - 114
  • [24] Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson's disease
    Arabia, G.
    Grossardt, B. R.
    Geda, Y. E.
    Carlin, J. M.
    Bower, J. H.
    Ahlskog, J. E.
    Maraganore, D. M.
    Rocca, W. A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S52 - S52
  • [25] Diabetes and the Risk of Developing Parkinson's Disease in Denmark
    Schernhammer, Eva
    Hansen, Johnni
    Rugbjerg, Kathrine
    Wermuth, Lene
    Ritz, Beate
    DIABETES CARE, 2011, 34 (05) : 1102 - 1108
  • [26] Study of olfaction in relatives of patients with Parkinson's disease (PwPD)
    Izhboldina, O.
    Zhukova, I.
    Nikitina, M. A.
    Zhukova, N.
    Alifirova, V.
    Azhermacheva, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 746 - 746
  • [27] The detection rate of nigrostriatal dopaminergic denervation in minimally symptomatic first degree relatives of patients with Parkinson's disease is low
    Moore, R
    Ivanco, L
    Schimmel, K
    Ivanco, D
    Constantine, G
    Bohnen, N
    NEUROLOGY, 2006, 66 (05) : A133 - A134
  • [28] Fighting Parkinson's disease: The return of the mitochondria
    Zambrano, Kevin
    Barba, Diego
    Castillo, Karina
    Noboa, Luis
    Argueta-Zamora, Dariana
    Robayo, Paola
    Arizaga, Eduardo
    Caicedo, Andres
    Gavilanes, Antonio W. D.
    MITOCHONDRION, 2022, 64 : 34 - 44
  • [29] Investigation of the incidences of non-motor symptoms in first-degree relatives and the spouses of patients with Parkinson's disease
    Liu, J. B.
    Zhang, X. J.
    Liu, C. F.
    MOVEMENT DISORDERS, 2018, 33 : S745 - S745
  • [30] Family history of neurodegenerative disorders among first-degree relatives: Associations with Parkinson's disease
    Nelson, LM
    Van Den Eeden, SK
    Tanner, CM
    Shino, MY
    Bloch, DA
    Leimpeter, AA
    Bernstein, A
    NEUROLOGY, 2002, 58 (07) : A112 - A113